Document is current

Any future updates will be listed below

223 Anti-TnMuc1 CAR-T cells that are conditionally armed with IL12 eliminate adenocarcinomas in preclinical models

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0223

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark